Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
- 1 October 2003
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (8) , 1415-1420
- https://doi.org/10.1016/s0735-1097(03)01056-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary ModelCirculation, 2001
- Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated StentCirculation, 2001
- Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary RestenosisCirculation, 2001
- Determinants of Paclitaxel Uptake, Accumulation and Retention in Solid TumorsInvestigational New Drugs, 2001
- Arterial Paclitaxel Distribution and DepositionCirculation Research, 2000
- Late Coronary Occlusion After Intracoronary BrachytherapyCirculation, 1999
- Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary ArteriesCirculation, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJournal of the American College of Cardiology, 1992